Literature DB >> 27663405

Relapse of morphea during Nivolumab therapy for lung adenocarcinoma.

A Alegre-Sánchez1, P Fonda-Pascual2, D Saceda-Corralo2, E de Las Heras-Alonso2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27663405     DOI： 10.1016/j.ad.2016.07.013

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN： 0001-7310


× No keyword cloud information.
  2 in total

1.  Scleroderma-like syndrome associated with pembrolizumab.

Authors:  Silvia Suárez-Díaz; Rubén Coto-Hernández; Carmen Yllera-Gutiérrez; Carlos Álvarez-Fernández; Luis Trapiella-Martínez; Luis Caminal-Montero
Journal:  J Scleroderma Relat Disord       Date:  2020-02-18

2.  Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report.

Authors:  Ewan A Langan; Kaja Budner; Detlef Zillikens; Patrick Terheyden
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.